<"http://www.yourlawyer.com/practice_areas/defective_drugs">CareFusion Corporation, Alaris PC Units (Model 8015) – electronic infusion pumps – have been recalled in what has been deemed a Class I recall, the US Food and Drug Administrationâ€™s (FDA) most serious classification. The recall was initiated on July 13, 2010 by CareFusion Corporation, which is located atâ€¨10020 Pacific Mesa Boulevard,â€¨San Diego, California, 92121.
The recall involves the Alaris PC unit (model 8015); the Alaris PC Unit Model 8000 is NOT affected by this recall, said the FDA. The affected serial numbers are found on the companyâ€™s website here.
Class 1 recalls are the most serious type of recall and involve situations in which there is a reasonable probability that use of these products will cause serious adverse health consequences or death.
These devices were manufactured from December 20, 2008 through September 8, 2009 and distributed from December 20, 2008 through June 28, 2010.
Electronic infusion pumps deliver controlled amounts of medications or other fluids to patients through an intravenous (IV), intra-arterial (IA), epidural, and other acceptable routes of administration.
Under certain wireless network conditions, a communication error can occur, which freezes the PC Unit screen. This error may result in a delay of therapy and inability to make programming changes to current infusions. If the communication error occurs during infusion, infusion continues on all channels, as originally programmed, but cannot be modified. When this error occurs, stopping the infusion to make any modification or programming changes causes the PC unit to shut down, resulting in a delay or interruption in therapy. This could lead to serious injury and/or death.
The CareFusion Recall Support Center can be reached Monday through Friday, from 7:00 a.m. to 4:00 p.m., Pacific Time, toll-free at 1-888-562-6018, or by email at SupportCenter@carefusion.com
On August 24, 2010, CareFusion sent its customers using the affected Alaris PC Units a recall notification letter with a Response Card by registered mail. Customers were required to confirm receipt of the notice by returning the Recall Response Card, by FAX or mail.
The recall notice informed the customers of the reason for the recall, the units affected, the potential risk, a step-by-step description of the issue, and the required actions for users. CareFusion will contact the affected facilities by phone or in person within 60 days of receipt of the recall notice to initiate corrective action.
The corrective action will require a hardware update to all affected units. CareFusion does not require that the devices be returned.
Until corrective action is taken, if users experience the problem, they are to remove the device from service and contact the CareFusion Recall Center immediately.